DrugRisk has received troubling new information about the popular antipsychotic drug Risperdal. The manufacturer has pled guilty to falsely marketing the drug, and experts have warned that it may cause abnormal breast growth in patients, especially children and adult males.
Earlier this year, a study from the American Medical Association raised concerns with the millions of patients taking diabetes drugs like Byetta when experts warned the drugs may be linked to higher risks of pancreatic cancer.
Since it was released in 2000, the Mirena IUD from Bayer has become one of the most popular forms of birth control. Nillions of women have chosen the one-time implant that can work for up to 5 years over the hassle of taking a daily pill.
For years, DrugRisk has tracked the research, warnings and legal action relating to the birth control drugs Yaz and Yasmin, in an effort to help the thousands of women affected by blood clot injuries.
Amid increasing warnings that the popular anticoagulant drug Pradaxa may present serious internal bleeding risks, and a growing number of lawsuits from patients and families who have been affected, DrugRisk learned that the maker of the drug went to the FDA last month for help.
Merck subsidiary Organon Pharmaceuticals is facing a growing number of lawsuits from women who suffered blood clot injuries while using the NuvaRing contraceptive device.
Within months of a major health warning by the American Medical Association about diabetes drugs like Byetta having a link to higher rates of pancreatic cancer, victims have started coming forward to seek help from the manufacturers that failed to warn them of the dangers.
The Mirena IUD from Bayer is one of the most popular and effective forms of birth control on the market, However, over the past decade, the FDA has logged over 70,000 complaints of Mirena side effects from patients and health care providers.
For several years now, health experts have disclosed troublesome findings that diabetes drugs like Januvia may be associated with higher rates of pancreatitis and pancreatic cancer.
As health experts and the big-pharma dominated FDA continue to disagree over whether the blood thinner Pradaxa is more dangerous than traditional treatments, more evidence has come out that should worry patients.